These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27052358)

  • 1. Patterns of use, harm reduction strategies, and their relation to risk behavior and harm in recreational ketamine users.
    Vidal Giné C; Fernández Calderón F; López Guerrero J
    Am J Drug Alcohol Abuse; 2016 May; 42(3):358-69. PubMed ID: 27052358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harm reduction behaviors among young polysubstance users at raves.
    Fernández-Calderón F; Lozano-Rojas Ó; Rojas-Tejada A; Bilbao-Acedos I; Vidal-Giné C; Vergara-Moragues E; González-Saiz F
    Subst Abus; 2014; 35(1):45-50. PubMed ID: 24588292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability, convergent and structural validity and cut-off score of the Severity of Dependence Scale for recreational ketamine users.
    Fernández-Calderón F; Vidal-Giné C; López-Guerrero J; Lozano-Rojas ÓM
    Addict Behav; 2016 Sep; 60():1-7. PubMed ID: 27082261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harm reduction strategies related to dosing and their relation to harms among festival attendees who use multiple drugs.
    Fernández-Calderón F; Díaz-Batanero C; Barratt MJ; Palamar JJ
    Drug Alcohol Rev; 2019 Jan; 38(1):57-67. PubMed ID: 30302851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine use: a review.
    Morgan CJ; Curran HV;
    Addiction; 2012 Jan; 107(1):27-38. PubMed ID: 21777321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Word of mouse": indigenous harm reduction and online consumerism of the synthetic compound methoxphenidine.
    Van Hout MC; Hearne E
    J Psychoactive Drugs; 2015; 47(1):30-41. PubMed ID: 25715070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges and opportunities to integrating family members of injection drug users into harm reduction efforts within the Atlantic Canadian context.
    Jackson LA; Dykeman M; Gahagan J; Karabanow J; Parker J
    Int J Drug Policy; 2011 Sep; 22(5):385-92. PubMed ID: 21742479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users.
    Uosukainen H; Tacke U; Winstock AR
    Int J Drug Policy; 2015 Jan; 26(1):78-83. PubMed ID: 25107829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence and natural history of urinary symptoms among recreational ketamine users.
    Winstock AR; Mitcheson L; Gillatt DA; Cottrell AM
    BJU Int; 2012 Dec; 110(11):1762-6. PubMed ID: 22416998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent trends in the use of "club drugs": an Australian review.
    Degenhardt L; Copeland J; Dillon P
    Subst Use Misuse; 2005; 40(9-10):1241-56. PubMed ID: 16048815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drinking patterns and risk behaviors associated with combined alcohol and energy drink consumption in college drinkers.
    Brache K; Stockwell T
    Addict Behav; 2011 Dec; 36(12):1133-40. PubMed ID: 21840130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual identity and drug use harm among high-risk, active substance users.
    Chow C; Vallance K; Stockwell T; Macdonald S; Martin G; Ivsins A; Marsh DC; Michelow W; Roth E; Duff C
    Cult Health Sex; 2013; 15(3):311-26. PubMed ID: 23311592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing patterns of first injection across key periods of the French Harm Reduction Policy: PrimInject, a cross sectional analysis.
    Guichard A; Guignard R; Michels D; Beck F; Arwidson P; Lert F; Roy E
    Drug Alcohol Depend; 2013 Nov; 133(1):254-61. PubMed ID: 23726980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities.
    Marshall BD; Green TC; Yedinak JL; Hadland SE
    Int J Drug Policy; 2016 May; 31():25-31. PubMed ID: 26919826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Needle Fixation Profile: An Exploratory Assessment of Applicability in the Australian Context.
    Hinton S; Signal T; Ghea V
    Subst Use Misuse; 2015; 50(11):1449-52. PubMed ID: 26549690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls.
    Morgan CJ; Muetzelfeldt L; Curran HV
    Addiction; 2009 Jan; 104(1):77-87. PubMed ID: 19133891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus and HIV seroprevalences, sociodemographic characteristics, behaviors and access to syringes among drug users, a comparison of geographical areas in France, ANRS-Coquelicot 2011 survey.
    Weill-Barillet L; Pillonel J; Semaille C; Léon L; Le Strat Y; Pascal X; Barin F; Jauffret-Roustide M
    Rev Epidemiol Sante Publique; 2016 Sep; 64(4):301-12. PubMed ID: 26904917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erectile Dysfunction among People Who Use Ketamine and Poly-Drugs.
    Suppiah B; Vicknasingam B; Singh D; Narayanan S
    J Psychoactive Drugs; 2016; 48(2):86-92. PubMed ID: 27014841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance-use and sexual harm reduction strategies of methamphetamine-using men who have sex with men and inject drugs.
    Wilkerson JM; Noor SW; Breckenridge ED; Adeboye AA; Rosser BR
    AIDS Care; 2015; 27(8):1047-54. PubMed ID: 25837492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and behaviors of ketamine users in France in 2003.
    Reynaud-Maurupt C; Bello PY; Akoka S; Toufik A
    J Psychoactive Drugs; 2007 Mar; 39(1):1-11. PubMed ID: 17523580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.